Literature DB >> 24858524

Low bone mineral density in Friedreich ataxia.

Andreas Eigentler1, Wolfgang Nachbauer, Eveline Donnemiller, Werner Poewe, Rudolf W Gasser, Sylvia Boesch.   

Abstract

Friedreich ataxia (FRDA) is the most common inherited neurodegenerative ataxia. Apart from predominant neurological features an involvement of the skeletal system in terms of scoliosis and foot deformities is frequent. Disease-related falls, mobility restrictions, and wheelchair-dependency in later disease stages might additionally compromise bone structure in FRDA. The aim of this pilot study was to systematically evaluate the bone status in a representative FRDA cohort. Twenty-eight FRDA patients became enrolled in this cross-sectional study. Neurological assessment, a questionnaire comprising the history of fractures and osteoporosis as well as osteodensitometric measurements complemented with general and bone-specific laboratory parameters were performed. The WHO Fracture Risk Assessment tool (FRAX®) was applied, calculating the 10-year risk of suffering an osteoporotic fracture. Six patients (21.4 %) presented with a bone mineral density below the expected range for age in at least one of the examined sites (femoral neck, lumbar spine, and forearm) irrespective of their gender. Corresponding Z scores were significantly lower compared to normative values for the femoral neck and lumbar spine. Vitamin D status was insufficient in 11 and deficient in 8 FRDA patients. There was a strong negative correlation between ataxia severity, GAA repeat expansion and bone density in the femoral neck of FRDA patients. This is the first report of an increased rate of low bone mineral density in FRDA. Given the increased risk of falls, this data rectifies routine bone mineral density measurements in FRDA which may help to initiate therapeutic interventions to prevent this condition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24858524     DOI: 10.1007/s12311-014-0568-1

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  26 in total

1.  Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia.

Authors:  G Geoffroy; A Barbeau; G Breton; B Lemieux; M Aube; C Leger; J P Bouchard
Journal:  Can J Neurol Sci       Date:  1976-11       Impact factor: 2.104

2.  Vitamin D insufficiency among free-living healthy young adults.

Authors:  Vin Tangpricha; Elizabeth N Pearce; Tai C Chen; Michael F Holick
Journal:  Am J Med       Date:  2002-06-01       Impact factor: 4.965

Review 3.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

Review 4.  FRAX updates 2012.

Authors:  Eugene McCloskey; John A Kanis
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

5.  Friedreich's ataxia. Revision of the phenotype according to molecular genetics.

Authors:  L Schöls; G Amoiridis; H Przuntek; G Frank; J T Epplen; C Epplen
Journal:  Brain       Date:  1997-12       Impact factor: 13.501

Review 6.  Friedreich ataxia: the clinical picture.

Authors:  Massimo Pandolfo
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

Review 7.  Assessment of fracture risk.

Authors:  John A Kanis; Helena Johansson; Anders Oden; Eugene V McCloskey
Journal:  Eur J Radiol       Date:  2009-08-28       Impact factor: 3.528

8.  A study of bone mineral density in adults with disability.

Authors:  Eimear M Smith; Catherine M Comiskey; Aine M Carroll
Journal:  Arch Phys Med Rehabil       Date:  2009-07       Impact factor: 3.966

Review 9.  Diagnosis and treatment of Friedreich ataxia: a European perspective.

Authors:  Jörg B Schulz; Sylvia Boesch; Katrin Bürk; Alexandra Dürr; Paola Giunti; Caterina Mariotti; Francoise Pousset; Ludger Schöls; Pierre Vankan; Massimo Pandolfo
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

Review 10.  Osteoporosis in children and adolescents.

Authors:  Maria Luisa Bianchi
Journal:  Bone       Date:  2007-07-18       Impact factor: 4.398

View more
  9 in total

1.  Risk factors for poor bone health in primary mitochondrial disease.

Authors:  Shifa S Gandhi; Colleen Muraresku; Elizabeth M McCormick; Marni J Falk; Shana E McCormack
Journal:  J Inherit Metab Dis       Date:  2017-04-27       Impact factor: 4.982

Review 2.  Friedreich ataxia: clinical features and new developments.

Authors:  Medina Keita; Kellie McIntyre; Layne N Rodden; Kim Schadt; David R Lynch
Journal:  Neurodegener Dis Manag       Date:  2022-06-29

3.  Frataxin deficiency lowers lean mass and triggers the integrated stress response in skeletal muscle.

Authors:  César Vásquez-Trincado; Julia Dunn; Ji In Han; Briyanna Hymms; Jaclyn Tamaroff; Monika Patel; Sara Nguyen; Anna Dedio; Kristin Wade; Chinazo Enigwe; Zuzana Nichtova; David R Lynch; Gyorgy Csordas; Shana E McCormack; Erin L Seifert
Journal:  JCI Insight       Date:  2022-05-09

4.  Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.

Authors:  M Cavar; M Ljubkovic; C Bulat; D Bakovic; D Fabijanic; J Kraljevic; N Karanovic; Z Dujic; C J Lavie; U Wisloff; J Marinovic
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

5.  A Sparse Regression Method for Group-Wise Feature Selection with False Discovery Rate Control.

Authors:  Alexej Gossmann; Shaolong Cao; Damian Brzyski; Lan-Juan Zhao; Hong-Wen Deng; Yu-Ping Wang
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2017-12-06       Impact factor: 3.710

6.  Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study.

Authors:  Cecilia Smith Simonsen; Elisabeth Gulowsen Celius; Cathrine Brunborg; Chantal Tallaksen; Erik Fink Eriksen; Trygve Holmøy; Stine Marit Moen
Journal:  BMC Neurol       Date:  2016-12-05       Impact factor: 2.474

7.  Assessment of Bone Mineral Density of Patients with Spinocerebellar Ataxia Type 3.

Authors:  Aline Ms Farias; Simone Appenzeller; Marcondes C França; Alberto Rm Martinez; Elba E Etchebehere; Thiago F Souza; Allan O Santos
Journal:  J Mov Disord       Date:  2019-01-30

8.  Bone Mineral Density and Current Bone Health Screening Practices in Friedreich's Ataxia.

Authors:  Julia Dunn; Jaclyn Tamaroff; Anna DeDio; Sara Nguyen; Kristin Wade; Nicolette Cilenti; David R Weber; David R Lynch; Shana E McCormack
Journal:  Front Neurosci       Date:  2022-03-14       Impact factor: 5.152

9.  Identification of cardioprotective drugs by medium-scale in vivo pharmacological screening on a Drosophila cardiac model of Friedreich's ataxia.

Authors:  Amandine Palandri; Elodie Martin; Maria Russi; Michael Rera; Hervé Tricoire; Véronique Monnier
Journal:  Dis Model Mech       Date:  2018-07-20       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.